Sonal Pai’s Post

Going to the Aseptic Processing Summit 2024? Be sure to attend Andre Zdunczyk talk on small batch and next generation fillo g solutions in pharmaceutical machinery! #fillfinish #asepticprocessing

Join us at the Aseptic Processing Summit 2024 to hear from Andre Zdunczyk, Business Development & Marketing Director, North America at Bausch+Stroebel Machine Co.! 🌟 Andre's presentation, titled "Contemporary Small Batch Fill Finish Solutions and the Next Generation in Pharma Machinery," will highlight the remarkable evolution of flexible filling platforms for vials, syringes, and cartridges over the past decade. He will showcase successful case studies and innovations that have revolutionized pharmaceutical manufacturing processes. Looking ahead, Andre will delve into the cutting-edge advancements shaping the next era of pharmaceutical machinery. Key topics include: 🔹 Introduction of the linear motor container transport system for enhanced precision and speed 🔹 Role of robotics, artificial intelligence, and virtual reality in manufacturing optimization 🔹 Predictive maintenance and integrity testing innovations 🔹 Single-use technology and ready-to-use principles 🔹 Compliance with Annex 1 standards and specialized equipment for emerging therapies like cell and gene therapy and antibody-drug conjugates (ADCs) Don’t miss Andre’s visionary session at the Aseptic Processing Summit 2024, where he will explore how these transformative technologies are reshaping the future of drug manufacturing. 🔗 https://lnkd.in/eHdHR9sK #AsepticProcessing #PharmaceuticalManufacturing #Innovations #MedicalDevices #Annex1 #Machinery #Conference2024

Did you miss this event at Advanced Therapies Week? If so, read the full transcript of CEO J. Kelly Ganjei's reflections on why AmplifyBio is approaching manufacturing with hybrid options. What do we mean by a development "sandbox" for advanced therapies? Find out here: https://lnkd.in/e4tb44Vy

Early adoption of generative AI in commercial life sciences: Pilots of generative AI commercial use cases at biopharmaceutical and medtech companies have been promising, but success at scale hinges on a clear—and budgeted—gen AI strategy and custom solutions. http://dlvr.it/T6XqKt #InsightsonLifeSciences #Biotechnology #NorthandCentralAmerica

🔬 Exciting Announcement! 🔬 We are thrilled to announce that Aureka Biotechnologies, Inc. will be participating in PEGS Boston 2024, one of the most anticipated events in the biotech industry! Join us from May 13-17 as we delve into the latest advancements and innovations shaping the future of biologics. We are especially proud to have our VP of Biology, Dr. Alon Wellner, speaking at the Engineering track on the topic: "Rapid and Scalable Antibody Engineering by Autonomous Hypermutation in Yeast". He will be sharing insights into our groundbreaking approach, where antibody fragments are encoded on an error-prone DNA replication system and mutate through yeast culturing for antigen binding. This process swiftly produces high-affinity clones in under two weeks, enriching training data sets for our AI models. Don't miss out on this opportunity to gain invaluable knowledge and connect with industry leaders. Be sure to mark your calendars and join us at PEGS Boston 2024! #AurekaBiotechnologies #PEGSBoston #Biotech #Innovation #AntibodyEngineering #AI #GenerativeAI #AutonomousEvolution #YeastTechnology #Biologics

Completed a comprehensive online course on Artificial Intelligence and Machine Learning in Drug and Vaccine Development, offered by the Institute of Innovation. This program enhanced my understanding of how advanced AI/ML algorithms are leveraged to innovate and optimize biopharmaceutical research and development processes. #AI #MachineLearning #DrugDevelopment #VaccineDevelopment #Biotechnology #ProfessionalAdvancement

Big Pharma’s AI-focused partnerships leading to Q1 2023 In this report, we have profiled 800 actively developing AI-driven biotech companies. Steady growth in the AI for Drug Discovery sector can be observed in terms of the substantially increased amount of investment capital pouring into the AI-driven biotech companies ($2.28B in HY 2020 against $126.4B in HY 2022), the increasing number of research partnerships between leading pharma organizations and AI-biotechs, and AI-technology vendors, a continuing pipeline of industry developments, research breakthroughs, and proof of concept studies, as well as exploding attention of leading media and consulting companies on the topic of AI in Pharma and healthcare.  Some of the leading pharma executives increasingly see AI as not only a tool for lead identification but also a more general tool to boost biology research and identify new biological targets and develop novel disease models.  The main focus of AI research today is still on small molecules as a therapeutic modality. Read More: https://lnkd.in/dWkEyAbA #artificialintelligence #pharma #medicresai

🔬Dive into the future of #biotech! 💼🔬 Learn all about the booming #ViralVector and #PlasmidDNA Manufacturing Market in our latest #blogpost. Discover the cutting-edge #technologies driving advancements, the #keyplayers shaping the #industry, and the exciting potential for revolutionary therapies. Read out the blog now! https://bit.ly/3QUtpvS

Enjoyed these publications on decentralised manufacturing authored by Domhnall Mc Gowan at Canadian Advanced Therapies Training Institute and Erika Francoeur at Boston Labs. Across four papers the authors discuss a variety of topics: 🔆 1️⃣ the evolution of decentralised manufacturing from centralised manufacturing and its importance in ubiquitous access of these therapeutics https://lnkd.in/e-hFUN9D 🌟 2️⃣ the utilisation of emerging technologies within #cellandgenetherapies such automated closed systems, highlighted especially by the Miltenyi Biotec Prodigy and Lonza's Cocoon. Equipment for tracking and transport logistics for chain of custody and chain of identification with systems such Vineti feature too. Not mentioned but Hataali is another interesting system as well. A quick overview of quality management, QC & Product testing also ensues. https://lnkd.in/ekm4iRC7 😎 3️⃣ This post couldn't be published without a discussion on #skills as well. In the third publication the authors interview three individuals across some of the challenges in developing a competent and sustainable workforce within the sector. https://lnkd.in/eYZVAGmU 📊 4️⃣ Last but not least in the fourth installment an overview of CAR-T bioprocessing is provided with considerations on how decentralised manufacturing could provide new paradigms in therapeutics accessibility. https://lnkd.in/ekSQ2GAE Craig Hasilo, Benjamin McLeod, Spencer Knight, Ry Leahy #skills, #communitybuilding, #bioprocessing, #manufacturing,

Technological Advancements Fueling Flow Cytometry Growth 📈 Download PDF Brochure :-https://lnkd.in/ddb_bs4k Estimated at $5.1 billion in 2024, it's projected to soar to $10.3 billion by 2032, growing at a robust CAGR of 9.2%! 📈 Our in-depth research dives into industry trends, pricing strategies, patent insights, conference takeaways, key stakeholders, and purchasing behaviors. 🧐💡 Key drivers of this growth include: - Technological advancements 🔬 - Increased adoption in clinical diagnostics 🏥 - Rising prevalence of chronic diseases 💊 - Growing biopharmaceutical R&D 🧪 - The crucial need for precision medicine 🎯 Plus, the integration of AI and machine learning is revolutionizing data analysis, pushing the market even further! 🤖📊 #flowcytometry #biotechnology #biotech #cytometry